The researchers identified 30 patients who received outpatient total shoulder arthroplasty at a freestanding ASC and 30 patients who received the inpatient procedure at a hospital. These two cohorts were matched by both age and comorbidities. The researchers analyzed complications for these patients for 90 days following their procedure, including any readmissions or reoperations.
Here’s what you need to know:
1. No patient, in either the ASC or hospital cohort, required reoperation or readmission.
2. The complication rates were not significantly different — the ASC cohort had a complication rate of 13 percent and the hospital cohort had a complication rate of 10 percent.
3. In the ASC cohort, minor complications included arthrofibrosis and mild asymptomatic anterior subluxation.
4. In the hospital cohort, minor complications included mild asymptomatic anterior subluxation, blood transfusion and superficial venous thrombosis.
5. There was one major complication: an outpatient from the ASC cohort fell 11 weeks after surgery, which disrupted his subscapularis repair.
The researchers concluded that outpatient total shoulder arthroplasty is a safe alternative to traditional inpatient total shoulder arthroplasty. However, they emphasize that additional research is needed to evaluate the long-term outcomes of the outpatient procedure.
More articles on orthopedics:
Dr. Andrew Braziel joins New England Baptist Hospital: 3 things to know
X-ray more effective than MRI when diagnosing knee pain: 4 study insights
Dr. Robert Hunter works to improve orthopedic care in the military: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
